Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Centella asiatica Nanoparticles as Potential Acetylcholinesterase Inhibitors for Cognitive Decline Therapy Using the Ellman Method: an In Vitro Study

Folia Medica Indonesiana · Vol. 60 No. 4 (2024) · pp. 271–280

DOI
10.20473/fmi.v60i4.62182
ISSN
2355-8393, 2599-056X
Published
2024-12-11
Publisher
Airlangga University
Language
en
License
creativecommons.org/licenses/by-nc-sa/4.0/

Abstract

According to the World Health Organization (2021), cognitive impairment affects 65,6 million elderly people worldwide. Decreased cognitive function in the elderly is caused by neurocognitive changes and inflammation in nerve cells that can interfere with quality of life. Pegagan extract is known to have neuroprotective potential through the active compounds contained in it. An effective drug delivery system is needed so that the active compounds of the drug act as neuroprotective agents through the apoptosis signal inhibition pathway that can cross the blood brain barier (BBB) at adequate concentrations to provide neuroactive effects that support the potential use of this extract as neurotherapy. In this case, pEG-400 was chosen as the drug delivery system. This research was conducted at Universitas Airlangga by covering several stages of testing, namely the GC-MS test to identify active compounds in pegagan extract, tryptamine, γ-sitosterol and β-sitosterol which play a role in improving cognitive function. Synthesis shows that the 1:100 formulation between pegagan extract and pEG-400 produces ideal-sized nanoparticles (5-7 nm), which are optimal for penetrating the BBB. PSA and SEM tests support these results by showing homogeneous particle morphology and consistent chemical composition. High in vitro Ellman's reagent inhibition test with 97.63% effectiveness indicates that the 1:100 formulation is effective as an acetylcholinesterase inhibitor. The 1:1 and 1:100 formulations are very effective in acting as acetylcholinesterase inhibitors. This study shows that the combination of pEG-400 and pegagan extract has great potential as an innovative pharmacological therapy for such cases, but further research is needed to ensure the right dosage and development of research results.

Keywords

Collaboration network of the authors

40 authors · 103 co-authorship links · 20 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • University of Indonesia
  • State University of Malang
  • Tanjungpura University
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Sri Agus SudjarwoUniversitas Airlangga3
Aucky HintingUniversitas Airlangga3
Hamdani LunardhiUniversitas Airlangga2
Doddy Moesbadianto SoebadiUniversitas Airlangga2
Alis Nur DianaUniversitas Airlangga1
Sri PurwaningsihUniversitas Airlangga1
Reryd Arindany WiryawanAffiliation unknown1
Maria Paulina Budyandini Dyah PramestiUniversitas Airlangga1
Hamdani LunardhiAffiliation unknown1
Alivery Raihanada ArmandoUniversitas Airlangga1
Wihasto SuryaningtyasRumah Sakit Dokter Soetomo1
Candra Dwantara RamadhanRumah Sakit Dokter Soetomo1
Muhammad Fadhil KamaruddinUniversitas Airlangga1
Ramadhani Rizki ZamzamUniversitas Airlangga1
Evy WulandariUniversitas Airlangga1
Rahmawati RaharjoAffiliation unknown1
Arifa MustikaUniversitas Airlangga1
Sandra Dewi SitaresmiUniversitas Airlangga1
Ninik DarsiniUniversitas Airlangga1
R. Haryanto AswinUniversitas Airlangga1
Umie LestariState University of Malang1
Gondo MastutikUniversitas Airlangga1
Alphania RahniayuUniversitas Airlangga1
Isnin Anang MarhanaUniversitas Airlangga1
Mochamad AminUniversitas Airlangga1
Heru Fajar TriantoTanjungpura University1
Rina YudiwatiUniversitas Airlangga1
Tita Rudini YassinUniversitas Airlangga1
Rina YaudiwatiUniversitas Airlangga1
Mohammad Ayodhia SoebadiUniversitas Airlangga1
Kristophorus Jonathan WibowoAffiliation unknown1
Muhammad Hidayat Surya AtmajaAffiliation unknown1
Supardi SupardiAffiliation unknown1
Ria MargianaAffiliation unknown1
Fatkhurrohmah Leo AmaliaAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Centella asiatica Nanoparticles as Potential Acetylcholinesterase Inhibitors for Cognitive Decline Therapy Using the Ellman Method: an In Vitro Study</dc:title><dc:creator>Nathania Nathania</dc:creator><dc:creator>Selvina Cindy Kusumaningrum</dc:creator><dc:creator>Reny I’tishom</dc:creator><dc:creator>Feranita Kumalasari</dc:creator><dc:creator>Ria Margiana</dc:creator><dc:subject>Centella asiatica</dc:subject><dc:subject>nanoparticles</dc:subject><dc:subject>acetylcholinesterase inhibitors</dc:subject><dc:subject>cognitive decline</dc:subject><dc:subject>neuroprotection</dc:subject><dc:subject>blood-brain barrier</dc:subject><dc:subject>polyethylene glycol 400</dc:subject><dc:subject>drug delivery systems</dc:subject><dc:subject>tryptamine</dc:subject><dc:subject>γ-sitosterol</dc:subject><dc:subject>β-sitosterol</dc:subject><dc:subject>Ellman's assay</dc:subject><dc:subject>Alzheimer's disease</dc:subject><dc:description xml:lang="en">According to the World Health Organization (2021), cognitive impairment affects 65,6 million elderly people worldwide. Decreased cognitive function in the elderly is caused by neurocognitive changes and inflammation in nerve cells that can interfere with quality of life. Pegagan extract is known to have neuroprotective potential through the active compounds contained in it. An effective drug delivery system is needed so that the active compounds of the drug act as neuroprotective agents through the apoptosis signal inhibition pathway that can cross the blood brain barier (BBB) at adequate concentrations to provide neuroactive effects that support the potential use of this extract as neurotherapy. In this case, pEG-400 was chosen as the drug delivery system. This research was conducted at Universitas Airlangga by covering several stages of testing, namely the GC-MS test to identify active compounds in pegagan extract, tryptamine, γ-sitosterol and β-sitosterol which play a role in improving cognitive function. Synthesis shows that the 1:100 formulation between pegagan extract and pEG-400 produces ideal-sized nanoparticles (5-7 nm), which are optimal for penetrating the BBB. PSA and SEM tests support these results by showing homogeneous particle morphology and consistent chemical composition. High in vitro Ellman's reagent inhibition test with 97.63% effectiveness indicates that the 1:100 formulation is effective as an acetylcholinesterase inhibitor. The 1:1 and 1:100 formulations are very effective in acting as acetylcholinesterase inhibitors. This study shows that the combination of pEG-400 and pegagan extract has great potential as an innovative pharmacological therapy for such cases, but further research is needed to ensure the right dosage and development of research results.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2024-12-11</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v60i4.62182</dc:identifier><dc:identifier>10.20473/fmi.v60i4.62182</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 60 No 4 (2024); 271-280</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/62182/30862</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>